Division of Plastic Surgery, Hospital of the University of Pennsylvania, Philadelphia, PA, USA.
Division of Plastic Surgery, Hospital of the University of Pennsylvania, Philadelphia, PA, USA.
J Plast Reconstr Aesthet Surg. 2014 Jun;67(6):797-803. doi: 10.1016/j.bjps.2014.02.017. Epub 2014 Feb 21.
Preoperative anemia impacts a significant portion of breast reconstruction patients, though this does not appear to affect surgical outcomes. The impact of anemia on postoperative physical and mental health, however, is unknown. This study aimed to prospectively evaluate the role of preoperative anemia in recovery after autologous reconstruction.
From 2005 to 2010, we prospectively assessed autologous breast reconstruction patients with satisfaction surveys, strength and functional tests, and the short form 36 (SF36). Data was collected preoperatively and at early (<90d), intermediate (90-365d), and late (>365d) follow-up. We stratified patients by presence or lack of preoperative anemia (hemoglobin<12 g/dL).
Of 399 patients undergoing reconstruction, 179 enrolled in the study. Anemic patients (n = 31, 17%) had higher rates of preoperative chemotherapy (p = 0.02) and lower rates of radiation (p = 0.001). Preoperatively, anemic patients reported worse physical (p < 0.001), mental (p = 0.003) and overall health (p = 0.0003). These scores worsened postoperatively for anemic and nonanemic patients, though anemic patients had lower average scores in all SF36 categories. This was significant only for early follow-up physical health (p = 0.02). Change in SF36 scores and objective physical exam assessments did not differ between the two cohorts.
Though preoperative anemia may not impact surgical outcomes, it adversely impacts the recovery of breast reconstruction patients. Subjective physical health differences were significant in early follow-up, though this did not translate to differences in mental health or satisfaction. We advocate for preoperative optimization of hemoglobin to enhance the early recovery potential of breast reconstruction patients.
术前贫血影响了很大一部分接受乳房重建的患者,但这似乎并不影响手术结果。然而,贫血对术后生理和心理健康的影响尚不清楚。本研究旨在前瞻性评估术前贫血对自体重建后恢复的作用。
2005 年至 2010 年,我们通过满意度调查、力量和功能测试以及简明 36 项健康调查(SF36)前瞻性评估了接受自体乳房重建的患者。数据在术前和早期(<90d)、中期(90-365d)和晚期(>365d)随访时收集。我们根据术前是否存在贫血(血红蛋白<12g/dL)将患者分层。
在 399 例接受重建的患者中,有 179 例入组研究。贫血患者(n=31,17%)术前接受化疗的比例较高(p=0.02),接受放疗的比例较低(p=0.001)。术前,贫血患者报告的生理(p<0.001)、心理(p=0.003)和总体健康状况(p=0.0003)更差。贫血和非贫血患者术后这些评分均恶化,但贫血患者在所有 SF36 类别中的平均评分均较低。仅在早期随访时生理健康方面差异具有统计学意义(p=0.02)。两组 SF36 评分和客观体格检查评估的变化无差异。
尽管术前贫血可能不会影响手术结果,但它会对乳房重建患者的恢复产生不利影响。早期随访时,主观生理健康差异显著,但这并未转化为心理健康或满意度的差异。我们主张术前优化血红蛋白水平,以增强乳房重建患者的早期恢复潜力。